切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2016, Vol. 02 ›› Issue (02) : 83 -85. doi: 10.3877/cma.j.issn.2095-9141.2016.02.005

所属专题: 文献

临床研究

微创穿刺联合口服阿托伐他汀治疗慢性硬膜下血肿的疗效分析
曹德茂1, 武永康1,(), 王友伟1, 申宝玺1, 王鸿生1, 齐文涛1   
  1. 1. 225000 扬州,扬州市第一人民医院神经外科
  • 收稿日期:2015-05-25 出版日期:2016-04-15
  • 通信作者: 武永康

The effect of minimally invasive puncture combined with oral atorvastatin on chronic subdural hematoma

Demao Cao1, Yongkang Wu1,(), Youwei Wang1, Baoxi Shen1, Hongsheng Wang1, Wentao Qi1   

  1. 1. Department of Neurosurgery, the First People’s Hospital of Yangzhou, Yanzhou 225001, China
  • Received:2015-05-25 Published:2016-04-15
  • Corresponding author: Yongkang Wu
  • About author:
    Corresponding author: Yongkang, Email:
引用本文:

曹德茂, 武永康, 王友伟, 申宝玺, 王鸿生, 齐文涛. 微创穿刺联合口服阿托伐他汀治疗慢性硬膜下血肿的疗效分析[J]. 中华神经创伤外科电子杂志, 2016, 02(02): 83-85.

Demao Cao, Yongkang Wu, Youwei Wang, Baoxi Shen, Hongsheng Wang, Wentao Qi. The effect of minimally invasive puncture combined with oral atorvastatin on chronic subdural hematoma[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2016, 02(02): 83-85.

目的

探讨微创穿刺联合口服阿托伐他汀治疗慢性硬膜下血肿的效果、预后及复发。

方法

回顾性分析65例慢性硬膜下血肿患者,均进行微创穿刺,联合口服阿托伐他汀。

结果

65例患者均一次性治愈,并发不同程度气颅12例。术后癫痫l例。

结论

微创穿刺治疗慢性硬膜下血肿,具有手术时间短、操作简单、创伤小、恢复快等优点;联合口服阿托伐他汀,可有效降低复发率,改善预后,是适合临床推广的有效方法。

Objective

To explore the effect of minimally invasive puncture combined with oral atorvastatin in the treatment of chronic subdural hematoma.

Methods

To review and analyze 65 cases of chronic subdural hematoma which were treated with minimally invasive puncture combined with atorvastatin.

Results

All the patients were cured. 12 patients had different degrees of pneumocephalus and one patients had epilepsy.

Conclusion

The minimally invasive treatment of chronic subdural hematoma has the advantages of short operation time, quick recovery and if combined with oral atorvastatin, it can effectively reduce the recurrence rate, which is suitable for clinical promotion.

图1 患者口服阿伐他丁的前后CT对比
图2 患者术前术后口服阿伐他丁的前后CT对比
[1]
Almenawer SA,Farrokhyar F,Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34829 patients[J]. Ann Surg, 2014, 259(3): 449-457.
[2]
Lee L,Ker J,Ng HY, et al. Outcomes of chronic subdural hematoma drainage in nonagenarians and centenarians: a multicenter study[J]. J Neurosurg, 2015, 10(7): 1-6.
[3]
Tanaka Y,Ohno K. Chronic subdural hematoma-an up-to-date concept[J]. J Med Dent Sci, 2013, 60(2): 55-61.
[4]
D′Abbondanza JA,Loch Macdonald R. Experimental models of chronic subdural hematoma[J]. Neurol Res, 2014, 36(2): 176-188.
[5]
Lega BC,Danish SF,Malhotra NR, et al. Choosing the best operation for chronic subdural hematoma: a decision analysis[J]. J Neurosurg, 2010, 113(3):615-621.
[6]
肖智勇,胡志强,朱广通,等.软性神经内镜在慢性硬膜下血肿术中的应用[J].中华神经外科杂志, 2015, 31(9): 888-890.
[7]
Lu J,Shen D,Hu F, et al. An improved electronic twist-drill craniostomy procedure with post-operative urokinase instillation in treating chronic subdural hematoma[J]. Clinl Neurol Neurosurg, 2015, 136(9): 61-65.
[8]
Li T,Wang D,Tian Y, et al. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats[J]. J Neurol Sci, 2014, 341(1-2): 88-96.
[9]
Wang D,Li T,Tian Y, et al. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers[J]. J Neurol Sci, 2014, 336(1-2): 237-242.
[10]
Wood WG,Mller WE,Eckert GP. Statins and neuroprotection: basic pharmacology needed[J]. Mol neurobiol, 2014, 50(1): 214-220.
[11]
Tu Q,Cao H,Zhong W, et al. Atorvastatin protects against cerebral ischemia reperfusion injury through anti-inflammatory and antioxidant effects[J]. Neural Rege Res, 2014, 9(3): 268-275.
[12]
Martins WC,dos Santos VV,dos Santos AA, et al. Atorvastatin prevents cognitive deficits induced by intracerebroventricular amyloid-β1-40 administration in mice: involvement of glutamatergic and antioxidant systems[J]. Neurotox Res, 2015, 28(1): 32-42.
[13]
Drapkin AJ. Chronic subdural hematoma: pathophysiological basis for treatment[J]. Br Neurosurg, 1991, 5(5): 467-473.
[1] 中华医学会骨科学分会关节外科学组, 广东省医学会骨质疏松和骨矿盐疾病分会, 广东省佛山市顺德区第三人民医院. 中国髋部脆性骨折术后抗骨质疏松药物临床干预指南(2023年版)[J]. 中华关节外科杂志(电子版), 2023, 17(06): 751-764.
[2] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[3] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[4] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[5] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[6] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[7] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[8] 杨雪, 张伟, 尚培中, 宋创业, 尚丹丹, 张蔚. 胆囊十二指肠瘘结石经瘘口排出后自愈一例报道[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 707-708.
[9] 孔博, 张璟, 吕珂. 超声技术在复杂腹壁疝诊治中的作用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 670-673.
[10] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[11] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[12] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要